Results 81 to 90 of about 805 (127)

Bevacizumab for refractory gastrointestinal angiodysplasia: a case report and literature review. [PDF]

Eur J Gastroenterol Hepatol
Furumaya A, Goltstein LCMJ, Tushuizen ME, Klemt-Kropp M.   +3 more
europepmc   +1 more source

Acute kidney injury after TIPS in decompensated cirrhosis patients: a retrospective cohort study. [PDF]

BMC Nephrol
Jia M, Guo YD, Ye PP, Zhou XL, Luo Y.
europepmc   +1 more source

Re-Evaluating Transjugular Intrahepatic Portosystemic Shunt Candidacy for Patients with Kidney Disease. [PDF]

Kidney360
Griffin MM, Paine CH, Sanghavi SF, Sanghavi SF.   +3 more
europepmc   +1 more source

Australian best practice recommendations for transjugular intrahepatic portosystemic shunt (TIPS) in portal hypertension: a consensus statement. [PDF]

Hepatol Int
Kalo E, Holmes J, Bhat P, Hardikar W, Jagarlamudi N, Ma WS, Santhakumar C, Read S, Braund A, Chen FW, Gupta R, Collins K, Dev A, Grieve J, Koukounaras J, Lalloo S, Nguyen V, Mitchell T, Mott N, Raj A, Ranatunga D, Tallis C, Tse E, Valaydon Z, Robertson M, De Boo D, Gonsalkorala E, Muddassir R, Lam T, Tibballs J, Mitchell J, Fox P, Doyle A, Karamatic R, Macquillan G, Rogan C, George J, Shackel N, Roberts S, Olynyk J, Leggett B, Sood S, Strasser S, Popuri R, Lubel J, Levy M, Li J, O'Beirne J, Majumdar A, Ahlenstiel G, Gastroenterological Society of Australia (GESA).   +50 more
europepmc   +1 more source

Development of a deep learning model for guiding treatment decisions of acute variceal bleeding in patients with cirrhosis. [PDF]

World J Gastroenterol
Xiang Y, Yang N, Zheng TL, Huang YF, Liu TY, Ma DQ, Hu SJ, Zhang WH, Xiang HL, Zhang LY, Yuan LL, Wang X, Dang T, Zhang G, Wu B, Peng LJ, Gao M, Xia DL, Liu ZB, Li J, Song Y, Zhou XQ, Qi XS, Zeng J, Tan XY, Deng MM, Fang HM, Qi SL, He S, He YF, Ye B, Wu W, Shao JB, Wei W, Hu JP, Yong X, He CH, Bao JL, Zhang YN, Ji R, Bo Y, Yan W, Li HJ, Li SL, Geng S, Zhao L, Liu B, Qi XL.   +47 more
europepmc   +1 more source

Cardiovascular risk assessment and predictors of cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with cirrhosis. [PDF]

World J Gastroenterol
Tomassoni DR, Schildkraut T, Ramachandran V, Cooke JC, Sawhney R.   +4 more
europepmc   +1 more source

Incidence and efficacy of strategies for preventing hepatic encephalopathy following transjugular intrahepatic portosystemic shunt: A meta-analysis. [PDF]

World J Hepatol
Xu XT, Jiang MJ, Fu YL, Xie F, Li JJ, Meng QH.   +5 more
europepmc   +1 more source

Long-Term Outcomes of Extrahepatic Portal Vein Obstruction-A Nationwide Registry-Based Follow-Up Study From 1987 to 2023. [PDF]

Liver Int
Luoto T, Hukkinen M, Pakarinen MP.
europepmc   +1 more source

[A study on the efficacy and safety profile of transjugular intrahepatic portosystemic shunt received elderly patients with liver cirrhosis]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Cai ZH, Yin Q, Zhang F, Zhuge YZ.
europepmc   +1 more source

Investigation of bending angle algorithm and path planning for puncture needles in transjugular intrahepatic portosystemic shunt. [PDF]

Biomed Eng Online
Liao Q, Li B, Hu X, Huang X, Guo J, Zhu Y, He W.   +6 more
europepmc   +1 more source